Isolation and cytotoxicity of low-molecular-weight metabolites of Candida albicans

Frontiers in Bioscience

Volumn 13, Issue 18, 2008, Pages 6893-6904

  Kosalec, Ivan ^a   Puel, Olivier ^b   Delaforge, Marcel ^c   Kopjar, Nevenka ^d   Antolovic, Roberto ^e   Jelic, Dubravko ^e   Matica, Biserka ^f   Galtier, Pierre ^b   Pepeljnjak, Stjepan ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b CEMAGREF   (France)

^c CEA SACLAY   (France)

^d INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^e GLAXOSMITHKLINE   (United Kingdom)

^f Zagreb Institute of Public Health   (Croatia)

Author keywords

Biosynthesis; C. dubliniensis; Candida albicans; Candidosis; Cytotoxicity; Isolation; LC; Lymphocyte; Metabolites; MS; Tryptophol

Indexed keywords

CANDIDA ALBICANS;

MYCOTOXIN;

APOPTOSIS; ARTICLE; CANDIDA ALBICANS; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; LYMPHOCYTE; MASS SPECTROMETRY; NECROSIS; PHYSIOLOGY;

APOPTOSIS; CANDIDA ALBICANS; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LYMPHOCYTES; MASS SPECTROMETRY; MYCOTOXINS; NECROSIS;

EID: 52049112523     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3197     Document Type: Article

References (69)

1. Odds FC: Candida and Candidosis. Leicester: Leicester University Press (1979)
2. Fridkin SK, W. R. Jarvis: Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev. 9, 499-511 (1996) (Pubitemid 26366535)
3. Yang YL: Virulence factors of Candida species. J. Microbiol. Immunolo. Infect. 36, 223-228 (2003)
4. Osorio JJC, A. R. Román, J. Torre-Cisneros: Spectrum and risk factors of invasive fungal infection. Enferm Infect Microbiol Clin. 25, 467-76 (2007) (Pubitemid 47309633)
5. Hazen KC: New and emerging yeast pathogens. Clin. Microbiol. Rev. 8, 462-478 (1995)
6. Ribaud P: Fungal infections and the cancer patient, Eur. J. Cancer 33, S50-S54 (1997)
7. Molero G, R. Diez-Orejas, F. Navarro-Garcia, F. Monteoliva, L. Pla, C. Gil, M. Sanchez-Perez, C. Nombela: Candida albicans: genetics, dimorphism and pathogenicity. Internatl Microbiol. 1, 95-106 (1998) (Pubitemid 128731320)
8. Hobson RP: The global epidemiology of invasive Candida infections-is the tide turning? J. Hosp. Infect. 55, 159-168 (2003) (Pubitemid 37554904)
9. Sullivan D, D. Coleman: Candida dubliniensis: characteristics and identification. J. Clin. Microbiol. 36, 329-334 (1998) (Pubitemid 28060290)
10. Hawser SP, L. J. Douglas: Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun. 62, 915-921 (1994) (Pubitemid 24065575)
11. Sturtevan J, R. Calderone: Candida albicans adhensins: biochemial aspects and virulence. Rev. Iberoam. Micol. 14, 90-97 (1997) (Pubitemid 127525785)
12. Yang YL: Virulence factors of Candida species. J. Microbiol. Immunol. Infect. 36, 223-228 (2003)
13. Lo H J, JR Kohler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, G. R. Fink: Nonfilamentous C. albicans mutants are avirulent. Cell 90, 939-949 (1997) (Pubitemid 27381632)
14. Gutićrrez J, P. Morales, M. A. Gonzalez, G. Quindos: Candida dubliniensis: a new fungal pathogen. J. Basic Microbiol. 42, 207-27 (2002) (Pubitemid 34674242)
15. Whiteway M, U. Oberholzer: Candida morphogenesis and host-pathogen interactions. Curr. Opin. Microbiol. 7, 350-357 (2004) (Pubitemid 39091118)
16. Li CR, R. T. Lee, Y. M. Wang, X. D. Zheng, Y. Wang: Candida albicans hyphal morphogenesis occurs in Sec3pindependent and Sec3p-dependent phases separated by septin ring formation. J. Cell Sci. 120, 1898-907 (2007) (Pubitemid 46979781)
17. Kretschmar M, B. Hube, T. Bertsch, D. Sanglard, R. Merker, M. Schröder, H. Hof, T. Nichterlein: Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis. Infect. Immun. 67, 6637-6642 (1999)
18. Naglik JR, S. J. Challacombe, B. Hube: Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev. 67, 400-428 (2003) (Pubitemid 37122527)
19. Lian CH, W. D. Liu: Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis. Mycoses 50, 383-90 (2007) (Pubitemid 47256293)
20. Ghannoumn MA: Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev. 13, 122-143 (2000)
21. Stehr F, A. Felk , A. Gácser , M. Kretschmar , B. Mähnss , K. Neuber , B. Hube, W. Schäfer: Expression analysis of the Candida albicans lipase gene family during experimental infections and in patient samples FEMS Yeast Res. 4, 401-408 (2004) (Pubitemid 38156204)
22. Luo G, L.P. Samaranayake, J. Y. Y. Yau: Candida species exhibit differential in vitro hemolytic activities. J. Clin. Microbiol. 39, 2971-2974 (2001) (Pubitemid 32744023)
23. Luo GL, P. Samaranayake, B. P. Cheung, G .Tang: Reverse transcriptase polymerase chain reaction (RT-PCR) detection of HLP gene expression in Candida glabrata and its possible role in in vitro haemolysin production. APMIS 112, 283-90 (2004) (Pubitemid 39005911)
24. Kosalec I, B. Matica, N. Jarža-Davila, T. Maretić, J. Granić, S. Pepeljnjak: Haemolytic activity of Candida albicans and C. dubliniensis isolated from the oral cavity of immunocompromised patients. Clin. Microbiol. Infect. 12, 712 (2006)
25. Linares CE, E. S. Loreto, C. P. Silveira, P. Pozzatti, L. A. Scheid, J. M. Santurio and S. H. Alves: Enzymatic and hemolytic activities of Candida dubliniensis strains. Rev. Inst. Med. Trop. Sao Paulo 49, 203-206 (2007) (Pubitemid 47403201)
26. Slutsky B, J. Buffo, D. R. Soll: High-frequency switching of colony morphology in Candida albicans. Science 230, 666-9 (1985) (Pubitemid 16190959)
27. Vargas K, S. A. Messer, M. Pfaller, S. R. Lockhart, J. T. Stapleton, J. Hellstein and D. R. Soll: Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode. J. Clin. Microbiol. 38, 3595-3607 (2000)
28. Jin Y, Y. H., Samaranayake, H. K Yip, L. P. Samaranayake: Characterization of switch phenotypes in Candida albicans biofilms. Mycopathologia 160, 191-200 (2005) (Pubitemid 41415399)
29. Lewis RE, N. P. Wiederhold, J. Chi, X.Y. Han, K. V. Komanduri, D. P. Kontoyiannis, R. A. Prince: Detection of gliotoxin in experimental and human aspergillosis. Infect. Immun. 73, 635-637 (2005) (Pubitemid 40041162)
30. Lewis RE, N. P. Wiederhold, M. S. Lionakis, R. A. Prince, D. P. Kontoyiannis: Frequency and species distribution of gliotoxin-producing aspergillus isolates recovered from patients at a tertiary-care cancer center. J Clin. Microbiol. 43, 6120-6122 (2005) (Pubitemid 43100670)
31. Larone DH: Medically Important Fungi: A Guide to Identification. Washington D.C. ASM Press, 4th ed. (2002)
32. Al Mosaid A, D. J. Sullivan, D. C. Coleman: Differentiation of Candida dubliniensis from Candida albicans on Pal's Agar. J. Clin. Microbiol. 41, 4787-4789 (2003) (Pubitemid 37259795)
33. Frisvad JC: High-performance liquid chromatography determination profiles of mycotoxins and other secondary metabolites. J. Chromatogr. 392, 333-347 (1987) (Pubitemid 17064286)
34. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65, 55-63 (1983) (Pubitemid 14203433)
35. Singh NP: Microgels for estimation of DNA strand breaks, DNA protein crosslinks and apoptosis. Mutat. Res. 455, 111-127 (2000)
36. Duke RC, J. J. Cohen: Morphological and biochemical assays of apoptosis. In: J. E. Coligan, A. M. Kruisbeal (eds.) Current Protocols in Immunology. John Wiley and Sons. New York (1992)
37. Michel A: Mćtabolites secondaires d'Ophiostoma novoulmi et de Ceratocystis fimbriata sp. platani, pathogènes de l'orme et du platane, Facultć des Sciences, Universitć de Neuchâtel, PhD Thesis, 2001. (http://www.unige.ch/cyberdocuments/unine/theses2001/MichelA/these.html, accessed May 2007.)
38. Lingappa BT, M. Prasad, Y. Ligappa, D. F. Hunt, K. Biemann: Phenyethanol alcohol and tryptophol: autoantibiotics produced by the fungus Candida albicans. Science 163, 192-193 (1969)
39. Narayanan TK, R. Rao: Beta-indoleethanol and betaindolelactic acid production by Candida species: theirantibacterial and autoantibiotic action. Antimicro. Agents Chemother. 9, 375-380 (1976)
40. Kosalec I: Toxinogenicity and mechanism of action of virulence factors of Candida species, PhD Thesis, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia (2006)
41. Dickinson JR, L. E. J. Salgado, M. J. E. Hewlins: The catabolism of amino acids to long chain and complex alcohols in Saccharomyces cerevisiae. J. Biol. Chem. 278, 8028-34 (2003) (Pubitemid 36800541)
42. Chen H, M. Fujita, Q. Feng, J. Clardy, G. R. Fink: Tyrosol is a quorum-sensing molecule in Candida albicans. Proc. Natl. Acad. Sci. USA 101, 5048-5052 (2004) (Pubitemid 38469200)
43. Chen H, G. R. Fink: Feedback control of morphogenesis in fungi by aromatic alcohols. Gen. Develop. 20, 1150-1161 (2006)
44. Hornby JM, E. C. Jensen, A. D. Lisec, J. J. Tasto, B. Jahnke, R. Shoemaker, P. Dussault, K. W. Nickerson: Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67, 2982-2992 (2001) (Pubitemid 33644762)
45. Oh KB, H. Miyazawa, T. Naito, H. Matsuoka: Purification and characterization of an autoregulatory substance capable of regulating the morphological transition in Candida albicans. Proc. Natl. Acad. Sci. USA 98, 4664-4668 (2001) (Pubitemid 32295033)
46. Romano A: Dimorphism, In: G. C. Ainsworth and A. S. Sussman (eds.), The Fungi, vol. 2. New York: Academic Press (1966)
47. Nickerson KW, A. L. Atkin, J. M. Hornby: Quorum sensing in dimorphic fungi: farnesol and beyond. Appl. Envir.Microbiol. 72, 3805-3813 (2006) (Pubitemid 43894839)
48. Alem MAS, M. D. Y. Oteef, T. H. Flowers, L. J. Douglas: uction of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development. Eukaryot Cell 5, 1770-1779 (2006) (Pubitemid 44622603)
49. Shah DT, B. Larsen: Identity of a Candida albicans toxin and its production in vaginal secretions, Med Sci Res 20, 353-355 (1992)
50. Shah DT: Production of gliotoxin by Candida albicans and its effects on human polymorphonuclear leukocytes, PhD Thesis, West Virginia University (1993)
51. Shah DT, D. D. Glover, B. Larsen: In situ mycotoxin production by Candida albicans in women with vaginitis. Gynecol. Obstet. Invest. 39, 67-69 (1995)
52. Kupfahl C, T. Ruppert, A. Dietz, G. Geginat, H. Hof: Candida species fail to produce the immunosuppressive secondary metabolite gliotoxin in vitro. FEMS Yeast Res. 7, 986-992 (2007) (Pubitemid 47256364)
53. Kosalec I, S. Pepeljnjak, M. Delaforge, O. Puel, P. Galtier: Possible toxicity of clinical isolates of C. albicans, 3rd Croatian Microbiological Congress, 4-7 October 2004, Poreč, Croatia, 115 (2004)
54. Kosalec I, S. Pepeljnjak: The toxinogenicity of clinical isolates of Aspergillus and Candida species, Scientific symposium: Mycotoxins-clinical aspects and prevention, S. Pepeljnjak (Ed.), 44-45, a.z.p. Grafis, Zagreb (2004)
55. Seed JR, J. Sechelski: Tryptophol levels in mice injected with pharmacological doses of tryptophol, and the effect of pyrazole and ethanol on these levels. Life Sci. 21, 1603-1610 (1977) (Pubitemid 9038718)
56. Tizard I, K.H. Nielsen, J.R. Seed, J. E. Hall: Biologically active products from African Trypanosomes. Microbiol Rev. 42, 661-81 (1978) (Pubitemid 9124705)
57. Cornford EM, W. D. Bocash, L. D. Braun, P. D. Crane, W. H. Oldendorf: Rapid distribution of tryptophol (3-indole ethanol) to the brain and other tissues. J. Clin. Invest. 63, 1241-128 (1979)
58. Vincendeau P, S. Lesthelle, A. Bertazzo, M. C. Okomo- Assoumou, G. Allegri, C. V. Costa: Importance of Ltryptophan metabolism in trypanosomiasis. Adv. Exp. Med. Biol. 467, 525-531 (1999)
59. Cornford EM, P. D. Crane, L. D. Braun, W. D. Bocash, A. M. Nyerges, W. H. Oldendorf: Reduction in brain glucose utilization rate after tryptophol (3-indole ethanol) treatment. J. Neurochem. 36, 1758-1765 (1981) (Pubitemid 11083549)
60. Tanaka K, B. McConnell, W. P. Niemezura, H. F. Mower: Characterization and mutagenicity of 1- nitrosotryptophol and 6-nitrotryptophol possible genotoxic substances associated with smoking and alcohol consumption. Cancer Lett. 44, 109-116 (1989) (Pubitemid 19063175)
61. Some M, M. O. Beck, A. Helander: Acute interaction between ethanol and serotonin metabolism in the rat. LifeSci. 61, 577-583 (1997) (Pubitemid 27301390)
62. Seed JR, T. M. Seed, J. Sechelski: The biological effects of tryptophol (indole-3-ethanol): hemolitic, biochemical and behavior modifying activity. Comp. Biochem. Physio.l Part C: Comp. Pharmacol. 60, 175-185 (1978) (Pubitemid 8396683)
63. Ackerman SB, J. R. Seed: The effects of tryptophol on immune responses and its implications towards trypanosome-induced immunosupression. Experientia (Basel) 15, 645-647 (1976)
64. Kosalec I, N. Kopjar, S. Ramić, V. Bačun-Družina, S. Pepeljnjak: Genotoxicity and mutagenicity of tryptophol from Candida albicans, Central European symposium "Power of Microbes in Industry and Environment", Zadar, 19-22 September 2007, 116 (2007)
65. Inagaki S, S. Morimura, K. Gondo, Y. Tang, H. Akutagawa, K. Kida: Isolation of tryptophol as anapoptosis-inducing component of vinegar produced from boiled extract of black soybean in human monoblastic leukemia U937 cells. Biosci. Biotechnol. Biochem. 71, 371-379 (2007)
66. Inagaki S, S. Morimura, Y. Tang, H. Akutagawa, K. Kida: Tryptophol induces death receptor (DR) 5-mediated apoptosis in U937 cells. Biosci. Biotechnol. Biochem. 71, 2065-2068 (2007) (Pubitemid 350113157)
67. Kosalec I, S. Pepeljnjak: Chemistry and biological effects of gliotoxin. Arh. Med. Rada Toksikol. 55, 313-320 (2004) (Pubitemid 39524103)
68. DeWitte-Orr SJ, N. C. Bols: Gliotoxin-induced cytotoxicity in three salmonid cell lines: cell death by apoptosis and necrosis. Comp. Biochemi. Physiol. C, Toxicol. Pharmacol. 141, 157-167 (2005) (Pubitemid 41335485)
69. Gräbsch C, G. Wichmann, N. Loffhagen, O. Herbarth, A. Müller: Cytotoxicity assessment of gliotoxin and penicillic acid in Tetrahymena pyriformis. Environm Toxicol. 21, 111-117 (2006)